Sepsisli Hastalarda Hastane İçi Mortaliteyi Öngörmede D-dimer/Fibrinojen Oranının Prognostik Rolü

Yıl 2025, Cilt: 16 Sayı: 4, 630 - 636, 01.01.2026

Betül Çiğdem Yortanlı , Korhan Kollu

https://doi.org/10.18663/tjcl.1789502

Öz

Amaç: Bozulmuş koagülasyon ve fibrinoliz, sepsis patobiyolojisinin merkezinde yer almaktadır. Bu çalışma, sepsisli hastalarda D-dimer/fibrinojen oranının (DFR) hastane içi mortaliteyi öngörmedeki prognostik değerini değerlendirmeyi amaçladı.
Gereç ve Yöntem: Toplam 130 ardışık sepsis hastası incelendi. Tanıda Sepsis-3 kriterleri kullanıldı. Demografik ve klinik değişkenler ile birlikte APACHE II, SOFA, D-dimer, fibrinojen ve DFR değerleri kaydedildi. DFR ile hastane içi mortalite arasındaki ilişki, APACHE II ve SOFA skorlarıyla birlikte çok değişkenli modeller kullanılarak değerlendirildi. Ayırt edici gücü incelemek için ROC analizi yapıldı.
Bulgular: Hayatta kalamayan hastalarda APACHE II, SOFA ve DFR değerleri, sağ kalanlara göre daha yüksekti. Çok değişkenli analizde, artan APACHE II, SOFA ve DFR değerleri, hastane içi mortalitenin bağımsız yordayıcıları olarak bulundu. ROC analizinde DFR, mortalite için yüksek duyarlılık ve özgüllük gösterdi. Demografik özellikler ile sağkalım arasında ilişki saptanmadı.
Sonuç: DFR, hastane içi mortaliteyi bağımsız olarak öngören, pratik ve bilgilendirici bir biyobelirteçtir ve yerleşik şiddet skorlarını tamamlamaktadır. Bildiğimiz kadarıyla bu, DFR’nin sepsisli hastalarda özel olarak değerlendirildiği ilk çalışmalardan biridir. Bulgularımız, DFR’nin erken risk sınıflandırmasında ek değer sağlayabileceğini düşündürmektedir; ancak rutin kullanıma girmeden önce daha büyük ve çok merkezli kohortlarda doğrulanması gerekmektedir.

Anahtar Kelimeler

D-dimer/fibrinojen oranı , sepsis , hastane içi mortalite , APACHE II , SOFA , prognostik biyobelirteç

Etik Beyan

Bu çalışma, KTO Karatay Üniversitesi Tıp Fakültesi Etik Kurulu tarafından 26.09.2024 tarih ve 2024/004 karar numarası ile onaylanmış olup, Helsinki Deklarasyonu ilkelerine uygun olarak yürütülmüştür.

Destekleyen Kurum

Yoktur.

Teşekkür

Veri toplama sürecindeki desteklerinden dolayı Konya Şehir Hastanesi Yoğun Bakım Ünitesi çalışanlarına teşekkür ederiz.

The Prognostic Role of the D-dimer/Fibrinogen Ratio in Predicting In-hospital Mortality among Sepsis Patients

Öz

Aims: Dysregulated coagulation and fibrinolysis are central to sepsis pathobiology. This study evaluated the prognostic value of the D-dimer/fibrinogen ratio (DFR) for in-hospital mortality in patients with sepsis.
Methods: We analyzed 130 consecutive sepsis patients. The Sepsis-3 criteria were used to establish the diagnosis of sepsis. Demographic and clinical variables, APACHE II, SOFA, D-dimer, fibrinogen, and DFR were recorded at admission. The association between DFR and in-hospital mortality was assessed using multivariable models alongside APACHE II and SOFA. Discrimination was examined with ROC analysis.
Results: Non-survivors had higher APACHE II scores, SOFA scores, and DFR than survivors. In multivariable analysis, increasing APACHE II, SOFA, and DFR were each independent predictors of in-hospital mortality. DFR showed high sensitivity and specificity for mortality on ROC analysis. Demographic features did not correlate with survival.
Conclusion: DFR is a practical and informative biomarker that independently predicts in-hospital mortality in sepsis, complementing established severity scores. To our knowledge, this is among the first studies to evaluate DFR specifically in septic patients. Our findings suggest that DFR may provide additional value for early risk stratification, but external validation in larger, multicenter cohorts is warranted before its routine implementation.

Anahtar Kelimeler

D-dimer/fibrinogen ratio , sepsis , in-hospital mortality , APACHE II , SOFA , prognostic biomarker

Etik Beyan

This study was approved by the Ethics Committee of the Medical Faculty of KTO Karatay University (Approval date and number: 26.09.2024 – 2024/004) and conducted in accordance with the principles of the Declaration of Helsinki.

Destekleyen Kurum

None.

Teşekkür

The authors would like to thank the staff of the intensive care unit of Konya City Hospital for their support during the data collection process.

Kaynakça

• Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 2016; 315: 801-10.
• WHO. WHO calls for global action on sepsis - cause of 1 in 5 deaths worldwide. [Internet]. Available from: https://www.who.int (Accessed Jan 22, 2025).
• Mandal L, Rijal G, Singh R, Adhikari S, Thapa S, Sah SK et al. Sepsis among Patients Admitted to the Intensive Care Unit of a Tertiary Care Centre. JNMA J Nepal Med Assoc 2023; 61: 691-94.
• Blanco J, Muriel-Bombin A, Sagredo V, Taboada F, Gandía F, Tamayo L et al. Incidence, organ dysfunction and mortality in severe sepsis: a Spanish multicentre study. Crit Care 2008; 12: R158.
• Zhang L, Li X, Huang J, Zhang J, Fu J, Shen M et al. Predictive model of risk factors for 28-day mortality in patients with sepsis or sepsis-associated delirium based on the MIMIC-IV database. Sci Rep 2024; 14: 18751.
• Jarczak D, Kluge S, Nierhaus A. Sepsis-Pathophysiology and Therapeutic Concepts. Front Med (Lausanne) 2021; 8: 628302.
• Han YQ, Yan L, Zhang L, Ji JM, Mei QY, Xue MF et al. Performance of D-dimer for predicting sepsis mortality in the intensive care unit. Biochem Med (Zagreb) 2021; 31: 020709.
• Popescu NI, Lupu C, Lupu F. Disseminated intravascular coagulation and its immune mechanisms. Blood 2022; 139: 1973-86.
• Patel P, Walborn A, Rondina M, Fareed J, Hoppensteadt D. Markers of Inflammation and Infection in Sepsis and Disseminated Intravascular Coagulation. Clin Appl Thromb Hemost 2019; 25: 1076029619843338.
• Gando S, Shiraishi A, Yamakawa K, Ogura H, Saitoh D, Fujishima S et al. Role of disseminated intravascular coagulation in severe sepsis. Thromb Res 2019; 178: 182-88.
• Hayiroglu MI, Cinar T, Tekkesin AI. Fibrinogen and D-dimer variances and anticoagulation recommendations in Covid-19: current literature review. Rev Assoc Med Bras (1992) 2020; 66: 842-48.
• Chen R, Liu C, Zhou P, Deng Z, Li J, Liu X et al. Prognostic Value of D-dimer in patients with acute coronary syndrome treated by percutaneous coronary intervention: a retrospective cohort study. Thromb J 2021; 19: 30.
• Park J, Kim M, Kim JW, Choi HJ, Hong SH. Predictive Value of the D-Dimer-to-Fibrinogen Ratio for Acute Kidney Injury after Living-Donor Liver Transplantation. J Clin Med 2024; 13: 5499.
• Zhang L, Jiang J, Li J, Wang M, Zhou J. Prognostic value of D-dimer to fibrinogen ratio for patients with acute myocardial infarction. Eur J Inflamm 2022; 20: 1721727X221132381.
• Kara H, Bayir A, Degirmenci S, Kayis SA, Ak A, Az AO et al. D-dimer and D-dimer/fibrinogen ratio in predicting pulmonary embolism in patients evaluated in a hospital emergency department. Acta Clin Belg 2014; 69: 240-5.
• Chen L, Zhang M, Yu L, Zhang X, Huang Y, Chen S et al. The role of the D-dimer to fibrinogen ratio in the classification of cardioembolism and atherosclerotic stroke. J Clin Neurosci 2024; 125: 43-50.
• Seymour CW, Liu VX, Iwashyna TJ, Brunkhorst FM, Rea TD, Scherag A et al. Assessment of Clinical Criteria for Sepsis: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 2016; 315: 762-74.
• Qu X, Wang S, Ye X, Jiang G, Kuerban M, Xie Q. Prognostic value of baseline plasma D-dimer levels in sepsis: a prospective cohort study. Pract Lab Med 2025; 46: e00498.
• Wang G, Liu J, Xu R, Liu X. Elevated plasma D-dimer levels are associated with the poor prognosis of critically ill children. Front Pediatr 2022; 10: 1001893.
• Yao C, Zhang G, Zhang N, Zhang S, Jin Y, Dong H et al. Fibrinogen is associated with prognosis of critically ill patients with sepsis. Mediators Inflamm 2023; 2023: 7312822.
• Matsubara T, Yamakawa K, Umemura Y, Gando S, Ogura H, Shiraishi A et al. Significance of plasma fibrinogen level and antithrombin activity in sepsis: A multicenter cohort study using a cubic spline model. Thromb Res 2019; 181: 17-23.
• Mori K, Tsujita Y, Yamane T, Eguchi Y. Decreasing Plasma Fibrinogen Levels in the Intensive Care Unit Are Associated with High Mortality Rates In Patients With Sepsis-Induced Coagulopathy. Clin Appl Thromb Hemost 2022; 28: 10760296221101386.
• Kucher N, Kohler HP, Dornhofer T, Wallmann D, Lammle B. Accuracy of D-dimer/fibrinogen ratio to predict pulmonary embolism: a prospective diagnostic study. J Thromb Haemost 2003; 1: 708-13.
• Wuillemin WA, Korte W, Waser G, Lammle B. Usefulness of the D-dimer/fibrinogen ratio to predict deep venous thrombosis. J Thromb Haemost 2005; 3: 385-7.
• Alvarez-Perez FJ, Castelo-Branco M, Alvarez-Sabin J. Usefulness of measurement of fibrinogen, D-dimer, D-dimer/fibrinogen ratio, C reactive protein and erythrocyte sedimentation rate to assess the pathophysiology and mechanism of ischaemic stroke. J Neurol Neurosurg Psychiatry 2011; 82: 986-92.
• Zhao TJ, Yang QK, Tan CY, Bi LD, Li J, Miao ZL. Prognostic value of D-dimer/fibrinogen ratio in the adverse outcomes of patients hospitalized for heart failure. Biomark Med 2020; 14: 1733-45.
• Murat S, Murat B, Dural M, Mert GO, Cavusoglu Y. Prognostic value of D-dimer/fibrinogen ratio on in-hospital outcomes of patients with heart failure and COVID-19. Biomark Med 2021; 15: 1519-28.
• Zerman A, Aydin C, Zerman N. D-Dimer/Fibrinogen Ratio as a Prominent Predictor of Mortality in COVID-19 Patients Admitted To the Intensive Care Unit. Ahi Evran Med J 2025; 9: 17-23.
• Pavoni V, Gianesello L, Pazzi M, Dattolo P, Prisco D. Questions about COVID-19 associated coagulopathy: possible answers from the viscoelastic tests. J Clin Monit Comput 2022; 36: 55-69.